Drug Shortage Report for RAN-GABAPENTIN

Last updated on 2019-02-04 History
Report ID 19636
Drug Identification Number 02319055
Brand name RAN-GABAPENTIN
Common or Proper name RAN-GABAPENTIN
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Active Ingredient(s) GABAPENTIN
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-29
Actual start date 2018-10-29
Estimated end date 2019-01-15
Actual end date 2018-12-03
Shortage status Resolved
Updated date 2019-02-04
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2019-02-04 French Compare
v24 2019-02-04 English Compare
v23 2018-11-28 French Compare
v22 2018-11-28 English Compare
v21 2018-11-21 French Compare
v20 2018-11-21 English Compare
v19 2018-09-18 French Compare
v18 2018-09-18 English Compare
v17 2018-08-21 French Compare
v16 2018-08-21 English Compare
v15 2018-05-15 French Compare
v14 2018-05-15 English Compare
v13 2018-04-11 French Compare
v12 2018-04-11 English Compare
v11 2018-03-23 French Compare
v10 2018-03-23 English Compare
v9 2017-10-27 French Compare
v8 2017-10-27 English Compare
v7 2017-09-26 French Compare
v6 2017-09-26 English Compare

Showing 1 to 20 of 25